ES2884073T3 - Nuevos derivados antihelmínticos de quinolina-3-carboxamida - Google Patents

Nuevos derivados antihelmínticos de quinolina-3-carboxamida Download PDF

Info

Publication number
ES2884073T3
ES2884073T3 ES17791438T ES17791438T ES2884073T3 ES 2884073 T3 ES2884073 T3 ES 2884073T3 ES 17791438 T ES17791438 T ES 17791438T ES 17791438 T ES17791438 T ES 17791438T ES 2884073 T3 ES2884073 T3 ES 2884073T3
Authority
ES
Spain
Prior art keywords
alkyl
group
halogen atoms
haloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17791438T
Other languages
English (en)
Spanish (es)
Inventor
Walter Hübsch
Johannes Köbberling
Adeline Köhler
Hans-Georg Schwarz
Daniel Kulke
Claudia Welz
Thomas Ilg
Kirsten Börngen
Wei Zhuang
Nils Griebenow
Claudia Böhm
Niels Lindner
Maike Hink
Ulrich Görgens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elanco Animal Health GmbH
Original Assignee
Bayer Animal Health GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health GmbH filed Critical Bayer Animal Health GmbH
Application granted granted Critical
Publication of ES2884073T3 publication Critical patent/ES2884073T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES17791438T 2016-11-11 2017-11-06 Nuevos derivados antihelmínticos de quinolina-3-carboxamida Active ES2884073T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16198550 2016-11-11
PCT/EP2017/078319 WO2018087036A1 (en) 2016-11-11 2017-11-06 New anthelmintic quinoline-3-carboxamide derivatives

Publications (1)

Publication Number Publication Date
ES2884073T3 true ES2884073T3 (es) 2021-12-10

Family

ID=57321155

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17791438T Active ES2884073T3 (es) 2016-11-11 2017-11-06 Nuevos derivados antihelmínticos de quinolina-3-carboxamida

Country Status (26)

Country Link
US (2) US10889573B2 (enExample)
EP (1) EP3538512B1 (enExample)
JP (1) JP7165129B2 (enExample)
KR (1) KR102595730B1 (enExample)
CN (1) CN109890793B (enExample)
AU (1) AU2017357503B2 (enExample)
CA (1) CA3043298A1 (enExample)
CL (1) CL2019001292A1 (enExample)
CO (1) CO2019004776A2 (enExample)
DK (1) DK3538512T3 (enExample)
DO (1) DOP2019000117A (enExample)
ES (1) ES2884073T3 (enExample)
IL (1) IL266407B (enExample)
MX (1) MX2019005569A (enExample)
MY (1) MY196327A (enExample)
NZ (1) NZ752550A (enExample)
PH (1) PH12019501034A1 (enExample)
PL (1) PL3538512T3 (enExample)
PT (1) PT3538512T (enExample)
SG (1) SG11201903059SA (enExample)
SI (1) SI3538512T1 (enExample)
TW (1) TWI821165B (enExample)
UA (1) UA126119C2 (enExample)
UY (1) UY37480A (enExample)
WO (1) WO2018087036A1 (enExample)
ZA (1) ZA201903708B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7210483B2 (ja) 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
US11254661B2 (en) * 2017-08-04 2022-02-22 Bayer Animal Health Gmbh Quinoline derivatives for treating infections with helminths
MX2020006185A (es) * 2017-12-15 2020-09-03 Bayer Animal Health Gmbh Proceso para la preparacion de derivados de quinolina.
CN112074514B (zh) 2018-05-09 2024-10-29 礼蓝动物保健有限公司 新的喹啉衍生物
MX2021000293A (es) 2018-07-09 2021-07-15 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos antihelminticos.
EP3643711A1 (en) 2018-10-24 2020-04-29 Bayer Animal Health GmbH New anthelmintic compounds
US20220064159A1 (en) 2018-12-18 2022-03-03 Elanco Tiergesundheit Ag Bicyclic derivatives
NZ777370A (en) * 2018-12-18 2024-11-29 Elanco Tiergesundheit Ag Bicyclic derivatives
KR20220002890A (ko) 2019-03-19 2022-01-07 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 아자-벤조티오펜 및 아자-벤조푸란 화합물
US20200385398A1 (en) 2019-06-07 2020-12-10 Elanco Tiergesundheit Ag New bicyclic derivatives
TWI865563B (zh) 2019-07-30 2024-12-11 德商拜耳動物保健有限公司 新穎異喹啉衍生物
JP2023507173A (ja) * 2019-12-18 2023-02-21 インターベット インターナショナル ベー. フェー. キノリン構造を含む駆虫剤化合物
MX2022007671A (es) 2019-12-18 2022-07-19 Intervet Int Bv Compuestos antihelminticos que comprenden una estructura de azaindoles.
WO2021204930A1 (en) 2020-04-09 2021-10-14 Bayer Animal Health Gmbh Substituted condensed azines as anthelmintic compounds
BR112022024156A2 (pt) 2020-05-29 2023-02-14 Boehringer Ingelheim Animal Health Usa Inc Compostos heterocílicos antelmínticos
CN116685584A (zh) * 2020-11-18 2023-09-01 礼蓝动物保健有限公司 用于治疗心丝虫感染的n-(2,3-二氢-1,4-苯并噁嗪-4-基)-3-异丙基-7-(2,3,5-三氟苯基)苯并噻吩-2-甲酰胺衍生物和类似化合物
US20240059680A1 (en) 2020-11-18 2024-02-22 Elanco Tiergesundheit Ag N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
CN116888124A (zh) * 2020-12-04 2023-10-13 礼蓝动物保健有限公司 二环衍生物
TW202237600A (zh) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 雙環衍生物
AU2021398540A1 (en) 2020-12-11 2023-06-22 Intervet International B.V. Anthelmintic compounds comprising a pyridine structure
WO2022122988A1 (en) 2020-12-11 2022-06-16 Intervet International B.V. Anthelmintic compounds comprising a thienopyridine structure
EP4148052A1 (en) 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
WO2023073641A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic pyrrolopyridazine compounds
EP4694887A1 (en) 2023-04-14 2026-02-18 Elanco Animal Health GmbH Long-term prevention and/or treatment of a disease by slo-1 inhibitors
CN121620507A (zh) 2023-08-02 2026-03-06 英特维特国际股份有限公司 具有驱虫活性的甲酰胺-4-喹啉化合物
WO2026078157A2 (en) 2024-10-10 2026-04-16 Elanco Animal Health Gmbh Slo-1 modulators for prevention and/or treatment of a disease
WO2026115027A1 (en) 2024-11-28 2026-06-04 Intervet International B.V. Carboxamide-4-quinoline compounds with anthelmintic activity

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
KR840000768A (ko) * 1982-07-23 1984-02-27 박이은 무연통의 무연탄 난로
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
KR101310073B1 (ko) 2004-10-20 2013-09-24 이하라케미칼 고교가부시키가이샤 3-트리아졸릴페닐설파이드 유도체 및 그것을유효성분으로서 함유하는 살충·살진드기·살선충제
WO2006103120A2 (en) * 2005-04-01 2006-10-05 Insa Rouen New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
EP1932844B1 (en) 2005-10-06 2015-09-02 Nippon Soda Co., Ltd. Cross-linked cyclic amine compounds and agents for pest control
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び/または予防剤
JP2010529144A (ja) 2007-06-08 2010-08-26 ヘリコン・セラピューティクス・インコーポレーテッド 治療用ピラゾロキノリン尿素誘導体
JP5268461B2 (ja) 2008-07-14 2013-08-21 Meiji Seikaファルマ株式会社 Pf1364物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
ES2468215T3 (es) 2008-12-12 2014-06-16 Syngenta Participations Ag N-oxipiperidinas espiroheteroc�clicas como plaguicidas
EP2480537A1 (en) * 2009-09-24 2012-08-01 Basf Se Aminoquinazoline compounds for combating invertebrate pests
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
KR20130080485A (ko) 2010-05-31 2013-07-12 신젠타 파티서페이션즈 아게 작물 강화 방법
AU2011297160B2 (en) 2010-08-31 2014-11-20 Mitsui Chemicals Crop & Life Solutions, Inc. Noxious organism control agent
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
EP2675440B1 (en) 2011-02-14 2020-03-25 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
JP2015502936A (ja) * 2011-11-28 2015-01-29 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company スルホンアミド駆虫薬
WO2013096151A1 (en) 2011-12-22 2013-06-27 Glaxosmithkline Llc Chemical compounds
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
US9006257B2 (en) 2012-02-09 2015-04-14 Glenmark Pharmaceuticals S.A. Bicyclic compounds as mPGES-1 inhibitors
CN104202981B (zh) 2012-03-30 2018-01-30 巴斯夫欧洲公司 防治动物害虫的n‑取代的吡啶亚基化合物和衍生物
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
CA2870090A1 (en) 2012-04-27 2013-10-31 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
AR094101A1 (es) * 2012-12-20 2015-07-08 Bayer Cropscience Ag Derivados de sulfuro de arilo y sulfoxido de arilo como acaricidas e insecticidas
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
EP2999333B1 (en) 2013-05-23 2018-06-13 Syngenta Participations AG Tank-mix formulations
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
KR20160072155A (ko) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
CN105636441B (zh) 2013-10-17 2018-06-15 美国陶氏益农公司 制备杀虫化合物的方法
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
JP6377245B2 (ja) * 2014-03-24 2018-08-22 グアンドン ジョンシェン ファーマシューティカル カンパニー リミテッド Smo阻害剤としてのキノリン誘導体
WO2016005276A1 (en) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Process for preparing fluorinated iminopyridine compounds
EA032914B1 (ru) 2015-02-17 2019-08-30 Ниппон Сода Ко., Лтд. Агрохимическая композиция
AU2016370779B2 (en) 2015-12-17 2019-07-25 Astex Therapeutics Limited Quinoline-3-carboxamides as H-PGDS inhibitors

Also Published As

Publication number Publication date
AU2017357503B2 (en) 2022-02-17
JP7165129B2 (ja) 2022-11-02
US11505545B2 (en) 2022-11-22
UA126119C2 (uk) 2022-08-17
SG11201903059SA (en) 2019-05-30
ZA201903708B (en) 2022-11-30
PH12019501034A1 (en) 2019-12-02
US20200024264A1 (en) 2020-01-23
CL2019001292A1 (es) 2019-09-27
WO2018087036A1 (en) 2018-05-17
JP2019535706A (ja) 2019-12-12
RU2019117917A (ru) 2020-12-11
CN109890793B (zh) 2022-11-18
TWI821165B (zh) 2023-11-11
DOP2019000117A (es) 2019-05-31
IL266407B (en) 2021-10-31
MY196327A (en) 2023-03-24
US20210115026A1 (en) 2021-04-22
KR102595730B1 (ko) 2023-10-27
PL3538512T3 (pl) 2021-11-22
EP3538512B1 (en) 2021-06-16
US10889573B2 (en) 2021-01-12
BR112019009529A2 (pt) 2019-07-30
KR20190076980A (ko) 2019-07-02
TW201829384A (zh) 2018-08-16
CO2019004776A2 (es) 2019-07-31
UY37480A (es) 2018-06-29
DK3538512T3 (da) 2021-07-05
PT3538512T (pt) 2021-08-16
AU2017357503A1 (en) 2019-05-02
MX2019005569A (es) 2019-09-05
CN109890793A (zh) 2019-06-14
CA3043298A1 (en) 2018-05-17
EP3538512A1 (en) 2019-09-18
NZ752550A (en) 2023-03-31
SI3538512T1 (sl) 2021-09-30
RU2019117917A3 (enExample) 2021-03-05
IL266407A (en) 2019-06-30

Similar Documents

Publication Publication Date Title
US11505545B2 (en) Anthelmintic quinoline-3-carboxamide derivatives
US10934301B2 (en) Pyrazolopyrimidine derivatives
ES2984497T3 (es) Nuevos derivados de azaquinolina
JP7455294B2 (ja) 蠕虫による感染を治療するためのキノリン誘導体
ES2998110T3 (en) New bicyclic pyrazole derivatives
ES2945559T3 (es) Derivados de quinolina antihelmínticos
JP7669343B2 (ja) イソキノリン誘導体および寄生虫感染の治療のためのそれらの使用
BR112021007771A2 (pt) novos compostos anti-helmínticos
JP2023521342A (ja) 駆虫性化合物としての置換縮合アジン類
EP4694887A1 (en) Long-term prevention and/or treatment of a disease by slo-1 inhibitors
RU2772283C2 (ru) Новые антигельминтные хинолин-3-карбоксамидные производные
BR112019028181B1 (pt) Novos derivados de azaquinolina
BR122025018421A2 (pt) Novos derivados de quinolina
BR112019009529B1 (pt) Novos derivados de quinolina
BR112020022619B1 (pt) Novos derivados de quinolina
BR112019022383B1 (pt) Novos derivados de pirazol bicíclico
BR122025018357A2 (pt) Derivados de quinolina para tratamento de infecções por helmintos
BR112020002348B1 (pt) Derivados de quinolina para tratamento de infecções por helmintos